1. Home
  2. COUR vs VCEL Comparison

COUR vs VCEL Comparison

Compare COUR & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COUR
  • VCEL
  • Stock Information
  • Founded
  • COUR 2012
  • VCEL 1989
  • Country
  • COUR United States
  • VCEL United States
  • Employees
  • COUR N/A
  • VCEL N/A
  • Industry
  • COUR Computer Software: Prepackaged Software
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • COUR Technology
  • VCEL Health Care
  • Exchange
  • COUR Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • COUR 1.8B
  • VCEL 2.1B
  • IPO Year
  • COUR 2021
  • VCEL 1997
  • Fundamental
  • Price
  • COUR $11.25
  • VCEL $34.05
  • Analyst Decision
  • COUR Buy
  • VCEL Strong Buy
  • Analyst Count
  • COUR 14
  • VCEL 6
  • Target Price
  • COUR $11.59
  • VCEL $61.50
  • AVG Volume (30 Days)
  • COUR 2.3M
  • VCEL 565.9K
  • Earning Date
  • COUR 10-23-2025
  • VCEL 07-31-2025
  • Dividend Yield
  • COUR N/A
  • VCEL N/A
  • EPS Growth
  • COUR N/A
  • VCEL 2045.40
  • EPS
  • COUR N/A
  • VCEL 0.13
  • Revenue
  • COUR $721,674,000.00
  • VCEL $249,119,000.00
  • Revenue This Year
  • COUR $9.31
  • VCEL $18.35
  • Revenue Next Year
  • COUR $5.64
  • VCEL $22.47
  • P/E Ratio
  • COUR N/A
  • VCEL $256.98
  • Revenue Growth
  • COUR 7.10
  • VCEL 16.13
  • 52 Week Low
  • COUR $5.76
  • VCEL $33.09
  • 52 Week High
  • COUR $13.56
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • COUR 50.55
  • VCEL 40.14
  • Support Level
  • COUR $10.77
  • VCEL $33.34
  • Resistance Level
  • COUR $11.79
  • VCEL $36.81
  • Average True Range (ATR)
  • COUR 0.34
  • VCEL 1.36
  • MACD
  • COUR -0.12
  • VCEL -0.13
  • Stochastic Oscillator
  • COUR 37.07
  • VCEL 20.14

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: